Because our findings established unique necessity and sufficiency of self-reactive CD8 T cells in AD-like pathophysiology, and further predicted previously unknown properties of the clinical disease, they support targeting CD8 T cells to improve diagnosis, treatment, and possibly prevention of sporadic human AD. Here, CD8A is linked to Alzheimer disease.